TrialCardiovascular drugs and therapy2018

Safety and Incidence of Cardiovascular Events in Chinese Patients with Acute Coronary Syndrome Treated with Ticagrelor: the 12-Month, Phase IV, Multicenter, Single-Arm DAYU Study.

Runlin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.